The following table is for layout only Goto Main Navigation | Goto Main Content | Goto Banner | Goto Logon Box | Goto Menu Bar | Goto Search Box | Goto Footer
 

 
Register
|
Return to Listing
Adalimumab for a 12 year old with Crohn’s disease with an inadequate response to infliximab
URL/File
 Adalimumab for paediatric Crohn's.doc [1​16.5K] - Downloaded 12 times. Last downloaded 29 Oct 2012 14:40.
FormatMS Word Document (.doc)
Home LocationLHO
National or RegionalRegional
start of decorative frame for
start of content for
Publication date25 Aug 2010
Creator(s)NHS Greenwich, London and South East Medicines Information
end of content for
end of decorative frame for
start of decorative frame for
start of content for
Is part of
end of content for
end of decorative frame for
start of decorative frame for
start of content for
Use of infliximab in a 12 year old child with Crohn’s disease
Increasing dose of infliximab for Crohn’s disease in patient losing response to standard dose
Adalimumab treatment for a patient with severe fistulating Crohn’s disease
Adalimumab therapy for severe Crohn’s disease
Evidence for adalimumab in the treatment of Crohn’s disease in a patient who has lost response to infliximab
More...
end of content for
end of decorative frame for
start of decorative frame for
start of content for
KeywordsAdalimumab
Clinical exceptions
Crohn's disease
Exceptional treatments
Individual funding requests
individual treatments
end of content for
end of decorative frame for
start of decorative frame for Type and Language
Type and Language
start of content for Type and Language
Resource Typereport
end of content for Type and Language
end of decorative frame for Type and Language